CDH2 and neoplasm: On the other hand, immunohistochemical staining showed that the expression of tumor progression markers such as N-cadherin, Vimentin, VEGF, Ki67, and Cyclin D1 was decreased along with the downregulation of VIRMA, except E-cadherin exhibited a contrary tendency (Fig. 6j).